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Advances in novel imaging techniques and molecular probes are now extending the 
opportunity of visualizing molecular targets of diseases. Molecular imaging provides 
anatomic as well as functional and pathological information to sense the expression of 
molecular biological events. In general, molecular imaging aims to target a specific cell 
type or tissue and visualize biological events in vivo at the molecular or cellular levels 
through specific probes. Molecular imaging is usually performed in conjunction with 
probes for specific targets. The objective of this dissertation is to explore molecular 
imaging by providing highly efficient photoacoustic nanocluster contrast agents to further 
validate in vivo molecular imaging, improve the therapeutic procedure, and study 
fundamental photoacoustic signal processes from cluster of nanoparticles. Initially, a 
photothermal stimuli-responsive photoacoustic nanocluster was designed and synthesized 
to provide highly sensitive dynamic contrast within tissue samples. The photoacoustic 
signal enhancement from clustering of nanoparticles was demonstrated by characterizing 
the photoacoustic signal from photothermal stimuli-responsive nanoclusters. After 
characterization, photothermal stimuli-responsive nanoclusters were injected into a mouse 
tissue and the dynamic photoacoustic response from the nanoclusters activated by an 
external laser source was observed. This activation can be repeatedly turned on by 
modulating input laser signals, suggesting a new route for dynamic photoacoustic contrast 
 viii 
imaging that will further improve the imaging contrast and more accurately guide the drug 
release process. Despite tremendous advantages of using these nanoparticles, their safety 
in a biological environment could be a major hurdle for their in vivo utilization. In order to 
avoid accumulation and long-term toxicity of nanoparticles, biodegradable nanoclusters 
consisting of sub-5 nm primary gold particles stabilized by a weakly adsorbed 
biodegradable polymer were introduced. The photoacoustic signal from biodegradable 
nanoclusters was quantitatively characterized. In addition, a photothermal stability of 
different sizes of biodegradable nanoclusters was investigated. These nanoclusters were 
then intravenously injected into mice and biodistribution of nanoparticles was observed. 
Finally, in vivo spectroscopic photoacoustic imaging was performed on tumor-bearing 
mice with antibody conjugated biodegradable nanoclusters. This research may provide a 
new opportunity for molecular imaging to help diagnose tumors at an early stage and 
promote clinical translation of these techniques. 
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Chapter 1: Introduction 
 
Cancer is one of the most challenging diseases in the world. It is the leading cause 
of death in developed countries and the second leading cause of death in the United States 
in 2011 [1]1. For many years, researchers have developed various diagnostic tools for the 
detection, differentiation, and staging of cancer at its curable stages, thus increasing the 
survival rates and reducing healthcare costs [2-4]. Moreover, medical imaging has been 
explored for developing non- or less-invasive, and highly targeted therapeutic tools with 
less adverse side effects through accurately monitoring and assessing the outcome of 
treatments. During recent decades, there has been a tremendous interest in exploiting the 
development of new medical imaging techniques capable of characterizing anatomical, 
structural, functional and metabolic characteristics of cancerous tissues [2, 3]. Recent 
advances in molecular and cellular biology indicated that understanding the cellular and 
molecular pathways of cancer can lead to diagnosis of the pathology at its early stages of 
development and affect the cancer treatment significantly [5]. In particular, the 
development of imaging contrast agents with specific targeting moieties expands the scope 
of several existing medical imaging modalities from their conventional anatomical and 
structural imaging to molecular and cellular imaging [5-8]. An optimal imaging modality 
to identify cancer at its early stages of development must have notable features such as 
being non-invasive (or minimally invasive), capable of high temporal and spatial resolution 
and able to provide information about cellular and molecular events with high sensitivity 
                                                 
1 Some parts of this introduction were published in the journal: M. Mehrmohammadi, S.J. Yoon, D. 
Yeager, and S.Y. Emelianov, “Photoacoustic imaging for cancer detection and staging,” Current Molecular 
Imaging, 2(1):89 - 105 (2013). 
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and specificity. Moreover, the ideal imaging modality must have minimal complexity and 
the potential of being widely available in clinical practice.  
Molecular photoacoustic (PA) imaging has shown great potential in combination 
with molecularly targeted nanoparticles with their highly absorptive properties at desired 
visible and near-infrared optical wavelength [9-17]. PA imaging is an emerging imaging 
modality, which is stable, cost effective and non-ionizing, providing functional and 
pathological information at high resolution in real time [18-21]. There are numerous studies 
currently exploring photoacoustic imaging using nanoparticles, since molecular PA 
imaging with nanoparticles is a relatively new imaging modality. 
The overall goal of this research is to demonstrate a novel imaging method using 
nanoclusters as PA contrast agents to validate in vivo molecular PA imaging to diagnose 
cancerous tissue. This dissertation includes the design and characterization of nanoclusters 
as photoacoustic contrast agents. In order to accomplish the goal of the project, 
photothermal stimuli-responsive nanoclusters are first developed and characterized to 
validate a PA signal enhancement. In addition, biodegradable nanoclusters are shown as a 
PA contrast agent which can be translated to the clinic.  
1.1 SIGNIFICANCE OF MOLECULAR IMAGING  
Over the past decades, physicians only could detect tumors or monitor their growth 
by surgery and biopsy. Despite the advent of modern medical imaging, they are still limited 
to detect tumors at their early stages. However, these recent advances in noninvasive 
medical imaging modalities allow us to open new opportunities for molecular diagnostic 
and therapeutic procedures. Molecular imaging provides anatomic as well as functional 
and pathological information in conjunction with probes to sense the expression of 
molecular biological events. In general, molecular imaging aims to target a specific cell 
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type or tissue and visualize biological events in vivo at the molecular or cellular levels 
through specific probes.  
Molecular imaging can be used to detect, characterize, and monitor early stage of 
tumor because the imaging of specific molecular targets which are associated with tumors 
can allow physicians to diagnose and manage oncology patients earlier. In addition, 
molecular imaging can investigate the efficacy of drugs. Currently, major imaging 
modalities capable of providing cellular and molecular information of cancer are optical 
imaging [22], magnetic resonance imaging (MRI) [23], and radionuclide imaging such as 
positron emission tomography (PET) [24] and single photon emission computed 
tomography (SPECT) [25]. These modalities have shown great capabilities and have been 
extensively studied in cancer diagnosis. However, they suffer from certain limitations such 
as system complexity and temporal resolution in MRI, limited imaging depth in optical 
imaging and limited spatial and temporal resolution in PET and SPECT. Therefore, there 
is still demand for the development of new robust imaging modalities, capable of 
addressing these limitations and reducing system complexity and implementation cost. 
 PA imaging has shown tremendous potential in cellular and molecular-specific 
imaging of cancer. The key advantages which make PA a suitable diagnostic modality for 
clinical applications are its ability to provide molecular information at clinically relevant 
depths with a high resolution and in real-time [9-17]. Moreover, it can be easily combined 
with US imaging as both imaging modalities have shared hardware components and 
common signal detection regimen. Therefore, through the combination of US and PA 
imaging, it is possible to obtain information on anatomical, functional, and molecular 
content of diseased tissues [18-21]. 
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1.2 PHOTOACOUSTIC IMAGING 
1.2.1 Principle of Photoacoustic Imaging 
PA imaging is based on the principles of photoacoustic effect that were first 
explored by Alexander Graham Bell in 1880 [26]. Photoacoustic techniques were initially 
studied in non-biological fields such as physics and chemistry [27, 28]. Since Theodore 
Bowen introduced PA imaging technique as a biomedical imaging modality in 1981 [29], 
this technology has been developing quite rapidly by several early adopters of 
photoacoustic imaging [30-32].  
Fundamentally, the photoacoustic technique measures the conversion of 
electromagnetic energy into acoustic pressure waves [29]. In biomedical PA imaging, the 
tissue is irradiated with a nanosecond pulsed laser, resulting in the generation of an 
ultrasound wave due to optical absorption and rapid thermal (or thermoelastic) expansion 
of tissue (Figure 1.1) [33]. The initial pressure, p0, generated by an optical absorber, is 
described as 
0 ap F   
where F is the laser fluence at the absorber, μa is the optical absorption coefficient, 
and Г is the Grüneisen parameter of the tissue [34]. By detecting the pressure waves using 
an ultrasound transducer, an image can be formed with the primary contrast related to the 
optical absorption of tissue. This unique mechanism through which a PA image is 
generated provides distinct advantages compared to other in vivo imaging modalities. First, 
the contrast mechanism in PA imaging is based on the differences in optical absorption 
properties of the tissue components. PA imaging is suited for imaging structures with high 
optical coefficient such as blood vessels [35-37]. Second, PA imaging can be achieved 
using longer wavelengths in near-infrared (NIR) region, where tissue absorption is at a 
minimum. Light can penetrate up to several centimeters into biological tissues at 
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wavelengths in the near-infrared range while remaining under the safe laser exposure limits 
for human skin [38, 39].  
 
 
Figure 1.1: A diagram shows the main components of a PA imaging system and the 
mechanism of PA signal generation 
The photoacoustic technique enables imaging deeper into tissues than optical 
imaging methods that utilize ballistic or quasiballistic photons (e.g., optical coherence 
tomography or OCT) because photoacoustics does not rely on detection of photons – 
instead, weakly scattering acoustic waves are detected in response to laser irradiation. 
Third, a PA imaging system can be easily combined with an US system because both 
systems can share the same detector and electronics. The primary contrast in US imaging 
is derived from the mechanical properties of the tissue, which mostly describes anatomical 
information. Therefore, combined PA and US system can provide both anatomical and 
functional information [40].  
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In PA, imaging depth is limited by light penetration and acoustic attenuation. In 
practice, the incident laser light and acoustic wave generated by the light beam will be 
attenuated in the tissue. However, the penetration depth is primarily limited by the optical 
scattering – a dominant component of the optical attenuation in the tissue. Specifically, the 
optical penetration depth is determined by the effective extinction coefficient μeff = (3μa (μa 
+ μ′s))1/2 obtained from diffusion theory, where μa and μ′s are the absorption coefficient and 
reduced scattering coefficient of the tissue, respectively [41, 42]. At depths greater than 1 
mm, the light diffuses and decays exponentially with the exponential constant equal to μeff. 
The penetration depth is defined as the distance at which the intensity of the light inside 
the tissues falls to 1/e (~ 37%) of its intensity at the surface. The penetration depth, 1/μeff, 
is strongly wavelength-dependent and it may reach up to several centimeters in NIR region 
[38, 39].  
Spatial resolution of PA imaging at depth beyond quasiballistic penetration of 
photons is determined by characteristics of an ultrasound transducer. The lateral resolution 
is dependent on numerical aperture (NA) and the center frequency of the transducer. The 
axial resolution is inversely proportional to the frequency bandwidth of the transducer [21, 
43]. Therefore, a transducer with large NA, higher center frequency and higher bandwidth 
provides the best spatial resolution. In practice, sub-millimeter spatial resolution is 
achievable at depth up to several centimeters, and sub-100 μm is possible for penetration 
depth of several millimeters. Higher lateral resolution (~ 5 µm) in PA imaging can be 
achieved by using fine optical focusing within less than 1 mm imaging depth where the 
focused light is in the ballistic regime. In this case, the lateral resolution is determined by 
optical diffraction limit, however, the axial resolution is still limited by frequency 
bandwidth and acoustic attenuation [44]. Overall, spatial resolution of photoacoustic 
imaging decreases as imaging depth increases. 
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1.2.2 Photoacoustic Contrast Agents 
Endogenous Contrast Agents in Photoacoustic Imaging 
Biological tissues contain several kinds of endogenous chromophores that can 
generate PA signal. The main sources of endogenous contrast in PA imaging are 
hemoglobin, melanin, and lipids. Depending on the wavelength, these endogenous contrast 
agents may have strong absorption coefficients in comparison with other tissue 
constituents. Photoacoustic imaging has been used in various applications where 
endogenous chromophores are present, such as in the visualization of blood vasculature 
structure and melanoma [36, 37, 45-48]. The absorption coefficients of these chromophores 
are strongly wavelength dependent. Therefore, if PA imaging is performed at several 
wavelengths, referred to as spectroscopic PA imaging, it is possible to measure 
distributions of the chromophores [46, 48, 49]. The use of endogenous chromophores in 
biomedical imaging has two key advantages. First, the endogenous contrast agents are 
inherently biologically safe. Although exogenous contrast agents may provide strong 
contrast and ability to be targeted to specific molecules, one of the major obstacles, 
inhibiting the clinical use of exogenous contrast agents is safety, such as toxicity and 
retention in the body. Second, physiological and metabolic changes that differentiate 
pathological tissue from normal tissue can be monitored because endogenous contrast 
agents provide the physiological changes, such as oxygen saturation and vascular blood 
volume in the body [32, 50]. 
Exogenous contrast agents have been introduced to expand the application of PA 
imaging in several ways [11, 12, 51, 52]. First, since the PA signal depends on the optical 
absorption of the photoabsorber, utilizing exogenous contrast agents with large optical 
absorption at a desired wavelength can increase the PA signal [13, 53, 54]. This effect can 
subsequently allow imaging at greater depths or using lower optical fluence. Moreover, by 
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tuning the optical absorption of these exogenous contrast agents to fall in the “tissue optical 
window” where tissue components have minimal absorption, it is possible to increase the 
imaging contrast and depth [55-58]. Second, by utilizing small enough contrast agents 
(such as nanoparticles) that can extravasate from the vasculature, get close to and 
ultimately tag specific cells or molecules, PA imaging can be utilized to visualize events 
at the cellular and molecular levels [59-67].  
 
 
Figure 1.2: Optical absorption of endogenous photo absorbers in tissue. The optical 
window is shown with a yellow box. 
 
Moreover, having prior knowledge of the optical absorption of such contrast, opens 
a path to spectroscopic PA imaging, where the PA signals at several different wavelengths 
are utilized to suppress the signal from background tissue and thus reveal the presence of 
the contrast agents with a higher contrast [50, 60, 68-72]. Depending on the required 
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imaging depth, desired light source to be used, and delivery mechanism of nanostructures, 
the choice of exogenous contrast agents may change. 
Exogenous Contrast Agents for Photoacoustic Imaging 
 
 
Figure 1.3: The range where peak absorption of major PA imaging exogenous contrast 
agents falls in. The peak absorptions depend on several parameters such as 
size, geometry, optical cross-section, etc. SWNTs are shown to have a high 
optical absorption over a wide range of spectrum including optical window 
spectrum [98]. 
Currently, the major contrast agents for PA imaging are metallic nanostructures 
[17, 52, 53, 57, 60, 73-85], dyes (or fluorophores) [86-90], and single-walled carbon 
nanotubes (SWNTs) [15, 64, 80, 91-94]. Recently, new PA contrast agents such as 
perfluorocarbon droplets loaded with metallic nanostructures [95-97] were introduced to 
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further enhance PA imaging abilities. Figure 1.2 summarizes the optical absorption of 
tissue components and the peak of optical absorption for several types of exogenous 
contrast agents used in PA imaging (Figure 1.3). 
Contrast-enhanced PA molecular imaging (i.e., PA imaging using molecular 
targeted exogenous contrast agents) can provide anatomical, functional and molecular 
information of diseased tissues at clinically relevant depths, with high spatial resolution 
and obvious contrast. Several research groups has shown the abilities of PA imaging 
augmented with molecular-targeted contrast agents to detect cancer at the cellular level 
[57, 60, 63, 65, 99]. Contrast enhanced PA imaging has shown great promise in its ability 
to detect primary tumors [64, 85], tumor vasculature [100], circulating tumor cells (CTCs) 
[16, 63, 101, 102], and micro-metastasis in sentinel lymph nodes (SNL) [88, 103]. Table 1 
summarizes some reported research studies related to exogenous contrast agent-assisted 
PA in detection of tumors, CTCs, mapping lymph nodes, and identifying lymphatic 
metastasis. 
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Table 1:  Summary of nano-sized contrast agents assisted PA in detecting tumors, 
CTCs, mapping lymph nodes and identifying lymphatic metastasis [98]. 
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1.2.3 Photoacoustic Signal Enhancement from Nanoclusters 
Recently, photoacoustic signal enhancement effect has been reported for different 
forms of aggregates or clusters. The enhancement of photoacoustic signal was observed 
from different forms of nanoparticle clusters including nanoparticle aggregation by cell 
endocytosis. Figure 1.4 represents an increase in photoacoustic signal from aggregated 
silica-coated gold nanoparticles in comparison to disperse nanorods. In these experiments, 
the photoacoustic signal of the aggregated nanoparticles produced 7 times higher 
photoacoustic signal compared to that of disperse nanoparticles. In general, the 
nanoparticles irradiated by pulsed laser generate heat which will be rapidly in the 
equilibrium state. The generated heat is transferred from the nanoparticles to the 
surrounding environment, and then, the environment undergoes thermal expansion which 
produces the pressure wave. The optical absorption properties of nanoparticles are the 
important factor which leads to the thermal expansion. However, the source of the 
photoacoustic signal enhancement from aggregated particles is not clear so far. It is likely 
that the signal enhancement occurs because of thermal interactions in a cluster of 
nanoparticles. When nanoparticles are aggregated, their thermal fields can overlap because 
of their small interparticle distance. The thermal coupling of nanoparticles may amplify the 
photoacoustic signal.  
The photoacoustic signal enhancement from clustering of nanoparticles can be 
further investigated using thermo-sensitive nanoclusters consisting of primary 
nanoparticles because the interparticle distance of the nanoclusters can be controllable by 
changing temperature. In addition, the photoacoustic signal enhancement effect can be 
utilized by any forms of cluster particles. 
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Figure 1.4: Photoacoustic signal of the aggregated and disperse nanoparticles as a 
function of fluence. (a) silica-coated gold nanorods at 3.7 × 1011 
nanoparticles/mL and (b) silica-coated gold nanosphere at 3.5 × 1012 
nanoparticles/mL [104]. 
1.3 OVERALL RESEARCH GOALS 
The overall goal of this work is to demonstrate a novel imaging method using 
nanoclusters as PA contrast agents to validate in vivo molecular PA images to diagnose 
cancerous tissue. In Chapter 2, the design and characterization of photothermal stimuli-
responsive nanoclusters is described. The photoacoustic signal enhancement from 
clustering of nanoparticles is demonstrated.  
In Chapter 3, photoacoustic signal from of photothermal stimuli-responsive 
nanoclusters is explored on an ex vivo animal model. To investigate their dynamic behavior 
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and repeatability, a continuous-wave (CW) laser is periodically turned on and off to heat 
the nanoclusters up.  
In Chapter 4, biodegradable nanoclusters which consist of sub-5nm primary gold 
nanoparticle stabilized by biodegradable polymer are introduced and characterized. 
Photoacoustic signal is analyzed quantitatively from a tissue mimicking phantom. In 
addition, the photothermal stability of different sizes of nanoclusters is investigated. In 
vitro and in vivo experiments are performed to detect tumors using antibodies conjugated 
to biodegradable nanoclusters on cancer cells. A tissue mimicking phantom with the 
inclusion of cells labeled with anti-EGFR (epidermal growth factor receptor) nanoclusters 
is prepared for photoacoustic signal measurement. In addition, mice are subcutaneously 
inoculated with EGFR expressing human A431 cells and EGFR-negative human MDA-MB-
435 cells are prepared and imaged before and after the injection of the antibody conjugated 
nanoclusters.  
Finally, Chapter 5 lists the overall conclusion and future directions.  
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Chapter 2: Design, Synthesis and Characterization of Photothermal 
Stimuli-responsive Nanoclusters  
 
Photoacoustic imaging is based on a process that converts photons to acoustic 
waves through thermal-elastic expansion of imaging targets by pulsed laser heating [1-4]. 
This process is dominated by optical absorption properties of materials, therefore, to 
develop a stimuli-responsive photoacoustic nanoparticle, one approach is to create a 
particle whose optical absorption varies with the stimulus signals. Stimuli-responsive 
fluorophores have been widely used in fluorescent imaging and partially adapted for 
photoacoustic imaging [5-8]. However, these fluorescent probes are not designed for 
releasing drugs. 
Another approach, instead, is to induce photoacoustic signal change from stimuli-
responsive particle aggregation. Nanoparticle photoacoustic contrast agents, unlike 
homogeneous medium, are optically and thermally heterogeneous after heated by external 
source. Thermal energy generated by optical absorption from the nanoparticles will diffuse 
out to their surrounding liquid. Since the particles are small, their thermal relaxation and 
diffusion time are much shorter than the duration of the illuminated laser pulse [9]. Once 
the nanoparticles move and their interparticle distances vary so that their heat profiles 
change from overlapping to non-overlapping or vice versa, their photoacoustic intensity 
will change upon this dynamics [10]. Therefore, a stimuli-responsive photoacoustic probe 
can be created by a nanocluster, whose particle packing density can vary dynamically in a 
controllable manner. It is known that many stimuli-responsive nanogels can recognize 
stimuli such as specific chemicals, pH value, temperature or light, and respond by changing 
volumes of particles [11, 12]. If one can incorporate photoacoustic contrast agents, such as 
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gold nanoparticles, into such volume changing stimuli-responsive nanogels, a dynamic 
contrast agent that helps to trace the stimulus responses can be created. 
In this chapter, photothermal stimuli-responsive nanoclusters are designed and 
characterized as photoacoustic contrast agents. The synthesis of the nanoclusters is first 
described. The photoacoustic signal enhancement from clustering of nanoparticles is 
demonstrated by altering the volume of nanoclusters. The photoacoustic signals from these 
nanoclusters are also compared to that of their primary particles.  
2.1 MATERIALS AND METHODS 
N-Isopropylacrylamide (NIPAm), cross-linking agent N-N’-methylene-bis-
acrylamide (BIS), and an initiator potassium persulfate (KPS), copper(II) chloride (CuCl2), 
sodium sulfide (Na2S•9H2O), sodium citrate, and methoxy-PEG-thiol (PEG-SH, MW 
5000) were purchased from Sigma-Aldrich (St. Louis, MO, USA). 
2.1.1 Nanoparticle Synthesis 
Poly(n-isopropylacrylamide) (PNIPAM) Nanogel Synthesis 
PNIPAM nanogel were prepared via free radical precipitation polymerization[13]. 
An aqueous solution (90 mL) containing monomer, N-isopropylacrylamide (12.5 mole), 
and cross-linker, N-N’-methylene-bis-acrylamide was placed in a 250 mL three necks flask 
with a reflux condenser. The solution was de-gassed under argon purge with mechanically 
stirring at 300 rpm for 15 minutes and then heated to 70 °C in water bath. At this point, 10 
mL of potassium persulfate solution (5 wt %) was injected in the flask through needle. 
Following synthesis, the PNIPAM nanogels were purified several times by centrifugation 
(20000g, 30 min at 20°C) and redispersed in ultrafiltrated (18 MΩcm, Thermo Scientific 
Barnstead Diamond water purification systems) deionized water.  
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Five nm Gold Nanoparticles 
To synthesize citrate-stabilized 5 nm gold nanospheres, 500 mL of nanopure water 
was heated to 97°C in an Erlenmeyer flask while covered. While stirring, add 1 mL of 1% 
of HAuCl4 solution. One minute later, 1 mL of 1% of sodium citrate solution was added to 
the solution. After one minute, 1 mL of 0.075% NaBH4 in a 1% sodium citrate solution 
was added to the solution. After 5 minutes of stirring, the solution is transferred to an ice 
bath to cool to room temperature.  
Copper Sulfide (CuS) Nanoparticle Synthesis 
CuS nanospheres (NSs) were synthesized by reacting copper(II) chloride (CuCl2) 
with sodium sulfide (Na2S)[14]. In particular, 1 mL of Na2S solution (1 M) was added to 
1L of an aqueous solution of CuCl2 (1 mM) and sodium citrate (0.68 mM), under stirring 
at room temperature for 5 minutes. The resultant brown color reaction mixture was, then, 
heated to 90 °C on a hotplate and stirred for another 15 min until a dark green solution was 
obtained. To introduce a polyethylene glycol (PEG) coating, about 1 mg of NH2-PEG-SH 
(5 kDa) was added into the citrate CuS NS solution. The reaction was stirred at room 
temperature overnight. 
PNIPAM-AuNS Nanocluster Synthesis 
Gold nanospheres in 5 nm diameter were prepared as described previously. The 
gold nanospheres were concentrated to OD of 5 using Amicon centrifugal filter tubes with a 
molecular weight cutoff of 100 kDa (EMD Millipore, Billerica, MA, USA) at 1500 × g for 5 
minutes. A mixture of 100 μL of concentrated AuNSs and 1 mL of the PNIPAM nanogels 
(2.0 wt% solid) were poured in a tube. The mixture was put into a shaker for overnight at 
room temperature and then washed several times by centrifugation at 3000 g for 10 
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minutes. The loading concentration is controlled by varying the concentration ratio of 
AuNSs to PNIPAM. 
PNIPAM-CuS Nanocluster Synthesis 
A mixture of CuS NSs and 1 mL of the PNIPAM nanogels (2.0 wt% solid) 
synthesized by the previously described protocol were poured in a tube. The mixture was 
put into a shaker for overnight at room temperature and then washed several times by 
centrifugation at 3000 g for 10 minutes. The loading concentration is controlled by varying 
the concentration ratio of CuS NSs to PNIPAM.  
Photoacoustic Signal Characterization 
To investigate the PA performance of PNIPAM-AuNS nanoclusters, their PA 
signals were characterized using a photoacoustic imaging system; the results were 
compared with the PA signals generated from their individual AuNSs. The extinction of 
PNIPAM-AuNS and AuNS solutions were matched using UV-Vis spectroscopy. An 
ultrasound and photoacoustic imaging system (Vevo LAZR, VisualSonics, Inc.) with a 20 
MHz array ultrasound transducer (MS250, VisualSonics, Inc.) was used to capture the 
photoacoustic signals at the wavelength of 700 nm. An optical fiber bundle for light 
delivery is integrated with the ultrasound transducer. The phantoms were made by first 
mixing each solution in 1:1 volume ratio with phenol-free Matrigel (Corning), a gelatinous 
protein that mimics the complex extracellular environment found in many tissues. Then, 
both mixtures were injected separately into thin wall polyethylene tubes (1 mm outer 
diameter and 0.6 mm inner diameter) and mounted on a plastic scaffold. The scaffold along 
with the tubes was placed in a water tank during imaging. The water inlet and outlet of the 
tank were connected to a temperature-controlled water circulator to maintain a constant 
and uniform temperature during imaging. The transducer with the fiber bundle was 
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mounted on top of the phantom with a fixed distance of 1 cm from the transducer to the 
tube inclusions, which was aligned perpendicularly with respect to the imaging plane of 
the transducer. Seven-nanosecond laser pulses produced by a wavelength-tunable optical 
parametric oscillator (Premiscan, GWU, Inc.) were used to excite photoacoustic signals. 
The laser fluence at the output of the fiber bundle was adjusted to 13 mJ/cm2. During the 
imaging, the water temperature was initially set at 21°C and gradually increased to 40°C 
by every 2°C, then it was cooled down to 21°C gradually. The water temperature stayed at 
each temperature for at least 5 minute before the PA images were recorded to allow 
sufficient thermal diffusion in samples. At each temperature, 300 PA signals of the 
phantom were collected for averaging. To plot the photoacoustic signal intensities as a 
function of temperature of each sample, the maximum PA intensities were selected at each 
temperature. These 300 signals were averaged and the standard deviation was calculated. 
The PA performance of PNIPAM-CuS comparing to pure CuS nanoparticle was measured 
with a similar manner at the wavelength of 970 nm. 
 2.2 CHARACTERIZATION OF PNIPAM NANOCLUSTER 
To demonstrate the design, a nanosize photothermal stimuli-responsive polymer, 
poly(n-isopropylacrylamide) hydrogel (PNIPAM), was selected as the model vehicle to 
carry and control the nanoparticle aggregation [15, 16]. The most appealing property of 
PNIPAM particle is that their volume rapidly reduces (de-swelling state or shrink state) 
when temperature rises above their lower critical solution temperature (LCST), a 
phenomenon that is caused by phase transition of hydrophobic moieties of polymer chain 
[16]. Moreover, this process is reversible: when temperature decreases, their volume will 
be recovered (swelling state). The LCST temperature of PNIPAM is 32°C, but it can be 
increased to match the biological temperature by co-polymerizing hydrophilic monomers 
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into the polymer matrix [17, 18]. Besides copolymers, some PNIPAM derivatives, such as 
poly (n-isopropylmethacrylamide) (PNIPMAM) also possess LCST at 38°C to 44°C [19]. 
PNIPAM based hydrogels have been widely used for controlling release of therapeutic 
agents such as genes and drugs [20, 21], tissue engineering, tunable catalysis, and sensing 
[22], therefore ideal for this purpose.  
 
 
Figure 2.1: (a) Structure of PNIPAM nanogels (b) Averaged diameter of PNIPAM 
below and above LCST. 
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Cross-linked PNIPAM nanogels were synthesized as described previously. The size 
of nanogels is average 700 nm in diameter at room temperature. After heating above LCST, 
these nanogels shrink to 350 nm in diameter (Figure 2.1b), corresponding to 12.5% of their 
original volume. Two commonly used photoacoustic contrast agents, gold nanosphere 
(AuNSs) and copper sulfide nanospheres (CuS NSs), are separately loaded into this 
nanogel to form two types of stimuli-responsive photoacoustic contrast agents [14, 23-26]. 
AuNSs are one of the most popular photoacoustic contrast agents because of their large 
optical cross section and inert chemical reactivity. Although the optical cross section of 
CuS NSs is lower than that of AuNSs, their inherent absorption peak close to the tissue 
second optical window (~1064 nm) make them also attractive photoacoustic contrast 
agents [27].   
2.3 RESULT AND DISCUSSIONS 
To investigate morphology changes of these PNIPAM-contrast agents nanoclusters 
caused by thermal stimulation, TEM samples were prepared at the temperatures below and 
above LCST, respectively. TEM images (Figure 2.2a-b and Figure 2.3a-b) at different 
temperature illustrate the swelling and deswelling state of these nanoclusters.  
Above LCST, the volume reduction of these nanoclusters results in changes of their 
optical properties. Optical absorption of nanoclusters is determined by plasmon resonance 
of AuNSs and plasmonic coupling between individual AuNSs. AuNSs have a plasmon 
peak around 520 nm due to the nature of gold and geometry. However, plasmonic coupling 
is strongly affected by the separation distance of AuNSs. The reduced separation between 
the individual AuNSs results in stronger plasmonic coupling and broadening of plasmonic 
peak. Indeed, the UV-Vis results (Figure 2.2c) show broadening of the spectrum.  
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Figure 2.2: (a) TEM images of PNIPAM-AuNS nanoclusters prepared at temperature 
below LCST. (b) TEM images of PNIPAM-AuNS nanoclusters prepared at 
temperature above LCST. (c) UV-Vis spectra of PNIPAM-AuNS at 25˚C 
(blue curves) and 42˚C (red curves). Scale bars are 500 nm (a, b). 
Unlike AuNSs, CuS NSs are semiconductor nanoparticles; their optical absorption 
is caused by electron transition overcoming their bandgap [14]. When CuS nanoparticles 
are brought closer to each other, the increase in their extinction is mainly due to the 
increased Rayleigh scattering of the nanoclusters (Figure 2.3a-b). 
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Figure 2.3: (a) TEM images of PNIPAM-CuS nanoclusters prepared at temperature 
below LCST. (b) TEM images of PNIPAM-CuS nanoclusters prepared at 
temperature above LCST. (c) UV-Vis spectra of PNIPAM-CuS at 25˚C 
(blue curves) and 42˚C (red curves). Scale bars are 500 nm (a, b). 
The morphology change of the nanoclusters can induce different photoacoustic 
responses. To demonstrate this, photoacoustic signal of these PNIPAM-nanoparticle 
nanoclusters using a customized photoacoustic imaging system was obtained. 
Photoacoustic intensities from pure AuNS and PNIPAM-AuNS solutions are compared. 
AuNS concentrations are first matched through UV-Vis spectroscopy. Photoacoustic signal 
as a function of the solution temperature between 22°C and 44°C (Figure 2.4a) was 
recorded. The results show the PNIPAM-AuNS solution produced higher photoacoustic 
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intensity than pure AuNS solution even below LCST. This photoacoustic signal 
enhancement is attributed to the randomly occurred thermal profile overlapping that creates 
a higher temperature gradient. Also at this temperature range, in both solutions, the 
photoacoustic intensity increases linearly with temperature. This increment comes from the 
thermal expansion coefficient of water that increases linearly in the range of this 
experiment from 21°C to 40°C [9]. When temperature is crossing LCST, in pure AuNS 
solution, the photoacoustic intensity keeps its linear trend, whereas in PNIPAM-AuNS 
solution, an abrupt intensity increase is observed. This abrupt increment happens from 
28 °C to 32 °C, close to the LCST of PNIPAM, corresponding the phase transition of 
PNIPAM, the sudden density increment of the loaded AuNS (or reduced particle spacing) 
causes the photoacoustic signal enhancement. Above the LCST temperature range (from 
32°C to 40°C), the photoacoustic intensity from PNIPAM-AuNS increases linearly with 
temperature again. As a result, its photoacoustic enhancement factor increases to more than 
45 times compared to pure AuNS solution at 36 °C at 700 nm. This result suggests that this 
unique photoacoustic signature caused by morphology changes of the nanoclusters can be 
used to monitor the dynamic morphology changes of the nanoclusters, a critical capability 
for image-guided controlled releasing. Besides, since this shrinking process of the 
nanoclusters is reversible, when the temperature is cooled down, the photoacoustic 
intensity reversely follows the curve back to its original intensity (Figure 2.4a). 
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Figure 2.4: Photoacoustic signal of PNIPAM-nanoparticle nanoclusters as a function of 
temperatures (a) Comparison of photoacoustic intensities for PNIPAM-
AuNS and pure AuNS with a heating and cooling cycle, indicating the curve 
retrieves back to its original PA intensity as temperature cools below LCST 
at the wavelength of 700 nm. Abrupt PA intensity changes are observed in 
both PNIMPAM-AuNS nanoclusters and (b), PNIPAM-CuS nanoclusters, 
whereas their pure nanoparticles (AuNS and CuS) show linear behavior with 
respect to temperatures at the wavelength of 970 nm. 
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Similarly, photoacoustic signal characterization was performed using PNIPAM-
CuS nanoclusters and pure CuS nanoparticle solutions. The reason of investigating 
PNIPAM-CuS is their improved photothermal stability from the spherical nature of CuS, 
this will eventually contribute to their repeatability as reusable stimuli-responsive agents. 
Although the trend for photoacoustic intensity increment is similar to PNIPAM-AuNS, 
their signal enhancement factor is slightly different. In this case, 2 times and 5.5 times 
enhancements were observed below and above LCST, respectively (Figure 2.4b). This 
difference could be due to the inherently lower absorption cross-section of the CuS 
nanoparticles, which require particles to pack even more densely to achieve higher signal 
enhancement.  
 
 
Figure 2.5: Photoacoustic signal enhancement factors as a function of loading 
concentrations of nanoparticles inside the nanoclusters. Photoacoustic signal 
enhancement factor as a function for CuS loading concentration below (blue 
points) and above LCST (red points). Insets show TEM images of the 
nanoclusters with increased loading density of CuSs. Scale bars are 250 nm. 
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To investigate whether photoacoustic signal enhancement can be further improved, 
PNIPAM-CuS with increasing loading concentrations of nanoparticles. As shown in the 
TEM images in insets of Figure 2.5, the CuS concentration is varied. With increased 
loading concentrations, PNIPAM-CuS starts to show advantages because of their small 
size. This small dimension allows much higher loading concentration of CuS into a single 
PNIPAM nanogel. As a result, much higher photoacoustic intensity increment is expected 
from the densely loaded PNIPAM-CuS nanoclusters. Four different loading concentrations 
of both PNIPAM-CuS and pure CuS nanospheres were prepared and tested their 
photoacoustic signal enhancement factors at 27 °C and 37°C respectively. A signal 
enhancement factor of 11.5 and 30 times below and above LCST were observed in the case 
of the highest loading concentration. 
2.4 CONCLUSION 
In this Chapter a new approach to visualize the dynamic stimulus responses of 
nanoparticles was introduced using photoacoustic imaging. A photothermal stimuli-
responsive nanoparticle whose photoacoustic intensity responds to light and thermal 
stimuli, ideal for a therapeutic agent vehicle, was designed and synthesized. Moreover, 
these smart nanoclusters can generate stronger photoacoustic signals comparing to the 
same concentration of their inorganic individual nanoparticle. The results suggest that a 
photoacoustic signal is amplified when nanoparticles are clustered. Therefore, the result 
demonstrated that nanocluster can be an effective photoacoustic contrast agents. 
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Chapter 3: Ex vivo Photoacoustic Imaging of Tissue using PNIPAM-
CuS Nanoclusters 
Targeted delivery and controlled release of therapeutic agents is crucial to optimize 
treatment for many diseases. Many therapeutic agents suffer from poor pharmacokinetics, 
therefore, require a vehicle that can carry these agents and well control their release to 
disease sites. Stimuli-responsive nanogels have recently shown great promises as such 
vehicles, because they can dynamically respond to micro-environmental changes. To 
maximize the outcome of the therapy and minimize the side effects, a proper imaging 
technique that can guide the delivery, validate the release and later noninvasively assess 
the efficacy of the therapeutic agents, is highly desired. Photoacoustic imaging has been 
used to guide thermal-, photodynamic-, and chemo- therapies, and to assess the therapeutic 
outcomes, especially in cancer treatments. Many of these capabilities are achieved with the 
facilitation of nanoparticles as imaging contrast agents. However, few nanoparticles can 
serve the dual purposes as the stimuli-responsive drug release vehicle, and at the same time, 
as a dynamic contrast agent that can reveal their dynamic releasing processes under stimuli. 
The experiments in the previous chapter were performed in an in vitro condition 
with external thermal heating. In this chapter, ex vivo photoacoustic imaging of a mouse 
tissue using PNIPAM-CuS nanoclusters is performed. The absorption peak of CuS 
particles is around 1000 nm, therefore, they can be imaged at the wavelength of 1064 nm. 
Despite lower absorption cross-section of CuS particles, there are several advantages using 
CuS nanoparticles over other plasmonic particles such as AuNSs or Au nanorods. First, 
background noise can be reduced because tissue is not absorbing as strong as in the other 
range [1]. Second, imaging depth can be increased because it has a low absorption and low 
scattering coefficients in biological tissues and a maximum allowable laser fluence is 
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higher [2]. In addition, one of the most reliable and cost effective Q-switched Nd:YAG 
laser can be used for photoacoustic imaging. However, tumor cells do not have specific 
optical absorption which can be differentiated from the background tissue at 1064 nm. To 
enhance the contrast of photoacoustic imaging, the strong contrast agents absorbing at 1064 
nm are required. CuS nanoparticles are one of the promising photoacoustic contrast agents 
that absorb light at 1064 nm. In addition, PNIPAM-CuS nanoclusters can provide 
additional contrast when the temperature is above the LCST. It is known that under 
continuous wave (CW) laser illumination, optical absorbing nanoparticles will also 
increase temperature rapidly [3]. This photothermal effect has been used for localized 
heating to annihilate cancer cells [4] and to trigger the drug release [5-7]. It suggests the 
photoacoustic contrast-enhanced nanoclusters can be noninvasively turned on with 
external lasers. 
3.1 MATERIALS AND METHODS 
 
 
Figure 3.1: TEM images of the PNIPAM-CuS nanoclusters for ex vivo imaging. (a) 
TEM sample was prepared at temperature below LCST which illustrates the 
swelling state of the nanoclusters, (b) sample was prepared at temperature 
above LCST illustrating the de-swelling state of the nanoclusters. 
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The procedure to make PNIPAM-CuS nanoclusters was discussed previously in 
Chapter 2.1.  
3.1.1 Animal Preparation 
For ex-vivo mouse imaging, a 12 week old Nu/Nu mouse was euthanized by carbon 
dioxide asphyxiation followed by cerebral dislocation. The CuS and PNIPAM-CuS 
samples (OD = 1.8) were mixed with Matrigel (Corning Inc., New York, NY, USA) at 1:1 
volume ratio and implanted subcutaneously into the flank of the mouse.  
3.1.2 Ultrasound and Photoacoustic Imaging with Countinous-wave Laser Heating 
The ultrasound and photoacoustic images were collected by VEVO 2100 LAZR 
system (Visualsonics Inc., Toronto, ON, Canada) with 20 MHz array ultrasound transducer 
(MS250, VisualSonics, Inc.). The photoacoustic images were collected at the wavelength 
of 1064 nm and the laser fluence was 23 mJ/cm2. The mouse was immersed in a water bath 
and 1.6 W continuous-wave at 1064 nm Nd:YAG laser was used for heating the area where 
the samples were injected. The CW laser is controlled by a function generator to turn on 
and off by a square waveform with a 30 second period.  
3.2 RESULTS AND DISCUSSION 
The photoacoustic responses of PNIPAM-CuS on an ex-vivo animal model (Figure 
3.2a) were obtained in comparison to regular photoacoustic contrast agents (CuS NSs) 
(Figure 3.2b-c). To test their dynamic behavior and repeatability, The CW lasers were 
periodically turned on. When the CW laser is on, CuS NSs instantaneously heat up the 
PNIPAM matrix and causes it to shrink. As evidenced in Figure 3.3, the periodic heating 
causes repeatedly enhancement of photoacoustic signals from the nanocluster region so 
that imaging depth can be increased into the tissue.  
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Figure 3.2: Ex-vivo Photoacoustic imaging of mouse. (a) A photograph a mouse model 
with both CuS NSs and PNIPAM-CuS injected in the region marked by the 
square. (b) Overlay of ultrasound and photoacoustic imaging show scattered 
air bubbles on the skin as a strong background noise before nanoparticle 
injection. (b) After nanoparticle injection, when the CW laser is off, the 
region with PNIPAM-CuS is clearly visualized, but the region with CuS 
NSs is relatively weak, and difficult to be distinguished from the bubble 
region. (d) When the CW laser is on, the PA intensity at the PNIPAM-CuS 
region is dramatically enhanced. 
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Besides the signal intensity enhancement that improves the imaging contrast and 
depth, the special signature of such dynamically changing signals can also be used to 
differentiate the PNIPAM-CuS nanoclusters from the background noises. Since the 
background noises (tissues and even bubbles) change very little when the CW laser is on 
and off, by subtracting PA intensities at the two states, the region with PNIMPAM-CuS 
nanoclusters are clearly revealed (Figure 3.4). The results show that PNIPAM-CuS 
nanoclusters produce dynamic contrast by CW laser irradiation. These PNIPAM-CuS 
nanoclusters provide several advantages over other contrast agents such as nanospheres, 
nanorods, and nanoshells [8-11].  
 
 
Figure 3.3: Quantitative photoacoustic signal analysis from the mouse. Multi-cycles of 
CW laser on and off shows the PA signals follow the CW laser on/off cycle 
dynamically. 
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Figure 3.4: Ex vivo photoacoustic imaging of mouse (a) PA intensity recorded during a 
full cycle of CW laser on and off, (b) dynamic contrast PA image obtained 
by subtracting the PA intensity under CW laser-off from CW laser-on, 
removing the strong background noises from the tissues, CuS NPs and 
bubbles, and unambiguously reveals the region with only the PNIPAM-CuS. 
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Since the PNIPAM-CuS nanoclusters provide dynamic contrast, they can be 
differentiated from background in real time. By simply using CW laser, the nanoclusters 
can be visualized. In addition, the nanoclusters do not require spectroscopic photoacoustic 
analysis for detecting the presence of nanoparticles due to their dynamic contrast. This 
allows us to save imaging time because photoacoustic imaging is needed at only one 
wavelength. Furthermore, computational power for post-processing can be significantly 
reduced [12-14].  
3.3 CONCLUSIONS 
Photoacoustic generation from the developed nanoclusters highlights several 
interesting characteristics: First, a polymeric nanogel-nanoparticle system that generates 
photoacoustic signals in response to thermal stimuli was created. More importantly, 
hybridizing strongly optical absorbing nanoparticles also give the polymer capability to 
respond to light, thus dynamic volumetric changes of the polymer can be triggered by light 
and captured by the abrupt photoacoustic variations. The stimuli-responsive nanoclusters 
are built with hydrogels that have been widely used for controllable drug release. By 
incorporating photoacoustic imaging technique, the nonlinear photo-induced photoacoustic 
signal variation provides the stimuli-responsive nanoclusters capabilities for validating the 
drug release process. In addition, the photothermal activation of the nanocluster results in 
the photoacoustic contrast enhancement, serving as a photoacoustic signal nanoamplifier 
that potentially reduces their required dosage and toxicity. Finally, this activation can be 
repeatedly turned on by modulating input laser signals, suggesting a new route for 
photoacoustic dynamic contrast imaging that will further improve the imaging contrast to 
guide the drug release process more accurately. 
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Chapter 4: Photoacoustic Imaging using Biodegradable Plasmonic 
Nanoclusters 
 
In recent years, there has been growing interest in metallic plasmonic nanoparticles 
for various biomedical applications including imaging, sensing, and therapeutics because 
the nanoparticles have strong scattering and absorption in the visible and near-infrared 
(NIR) regions [1]. Specifically, strongly absorbing gold nanoparticles have been shown as 
contrast agents in photoacoustic imaging [2-5]. These nanoparticles extend penetration 
depth and enhance sensitivity of photoacoustic imaging in-vivo. Furthermore, molecular 
and cellular photoacoustic imaging can be achieved by using targeted gold nanoparticles 
[3-6] 2. 
In addition to this, the photoacoustic signal enhancement from nanoclusters was 
demonstrated in chapter 2 and 3. It suggests that any form of nanoclusters can be a 
promising photoacoustic contrast agents. However, because of accumulation of 
nanoparticles and potential long-term toxicity, the safety of the nanoparticles in a biological 
environment could be a major hurdle for utilizing plasmonic nanoparticles in-vivo [7]. The 
size of commonly used nanoparticles in biomedical imaging application ranges between 
20 to 150 nm – these nanoparticles may not be easily removed from the body. Previous 
study indicates that particles smaller than ~6 nm in diameter are rapidly cleared from the 
body [8]. However, the nanoparticles within this size range do not have sufficient blood 
residence time for imaging and therapy because they are removed too rapidly from the 
                                                 
2 The results of Chapter 4.1 were published in the journal: S.J. Yoon, S. Mallidi, J.M. Tam, J.O. Tam, A. 
Murthy, K.P. Johnston, K.V. Sokolov, and S.Y. Emelianov, “Utility of biodegradable plasmonic 
nanoclusters in photoacoustic imaging,” Optics Letters, 35:3751-3753 (2010). The results for Chapter 4.2 
were published in the journal: S.J. Yoon, A.M. Murthy, K.P. Johnston, K.V. Sokolov, and S.Y. Emelianov, 
“Thermal stability of biodegradable plasmonic nanoclusters in photoacoustic imaging,” Optics Express, 
20(28):29479-87 (2012). 
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body. In addition, smaller nanoparticles produce smaller signal in comparison with larger 
nanoparticles [9]. 
 
Figure 4.1: Diagram of degradation of gold nanoclusters at different pH levels. 
Recently, non-toxic biodegradable plasmonic nanoclusters consisting of sub-5 nm 
primary gold particles stabilized by a weakly adsorbed biodegradable polymer have been 
reported [10, 11]. The small spacing between primary gold nanoparticles within the clusters 
results in strong near infra-red absorbance [12]. The nanoclusters, stable at pH 7, degrade 
into primary gold nanoparticles at around pH 5 (the environment inside of the endosomes) 
within about 7 days [10]. Once biodegraded, the 5 nm primary gold nanoparticles can be 
excreted from the body [13].  
In this chapter, the feasibility of biodegradable nanoclusters as a photoacoustic 
contrast agent is demonstrated. Photoacoustic and ultrasound imaging of a tissue 
mimicking phantom with inclusions containing nanoclusters at various concentrations are 
performed. In addition, photothermal stability of different sizes of the biodegradable 
nanoclusters is investigated.  
4.1 QUANTITATIVE PHOTOACOUSTIC IMAGING OF BIODEGRADABLE NANOCLUSTERS  
The results of this study were published in the journal: S.J. Yoon, S. Mallidi, J.M. 
Tam, J.O. Tam, A. Murthy, K.P. Johnston, K.V. Sokolov, and S.Y. Emelianov, “Utility of 
pH 7
pH 5
Biodegradable nanocluster Primary gold nanoparticles
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biodegradable plasmonic nanoclusters in photoacoustic imaging,” Optics Letters, 35:3751-
3753 (2010). 
4.1.1 Material and Methods  
The sub-100 nm clusters composed of primary 4-nm diameter gold nanoparticles 
were synthesized using previously published protocol [10, 11]. Briefly, 1 ml of a citrate-
capped gold nanoparticle dispersion was prepared at a concentration of 3 mg/ml Au. 42 µl 
of a 1% (w/v) lysine solution was then added to the dispersion and stirred for 15 min, in 
order to create a dispersion consisting of gold nanoparticles capped with a mixture of lysine 
and citrate ligands. This dispersion was then diluted with deionized water to 1 mg/ml Au, 
and 21 mg of the biodegradable polymer PLA(1k)-PEG(10k)-PLA(1k) was added to the 1 
mg/ml dispersion, resulting in a polymer/Au ratio of 7/1. The polymer-gold nanoparticle 
dispersion was bath sonicated for 5 min, and the resulting mixture was placed under an air 
stream and evaporated to a film. 2 ml of deionized water was then added to the dried film, 
and the mixture was bath sonicated for ~15 min, resulting in a dispersion of nanoclusters.  
 
Figure 4.2: (a) Normalized absorbance spectra and (b) TEM image of biodegradable 
nanoclusters. 
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The primary colloidal gold nanospheres have an absorbance peak at 520 nm (Figure 4.2a, 
solid line). However, the solution of 100 nm nanoclusters (see TEM image in Figure 4.2b) 
at pH 7 had a broad absorbance in NIR region where soft tissue and blood have low 
absorption (Figure 4.2a, dashed line). In contrast, after incubation at pH 5 for 1 week, the 
absorbance spectrum of the nanoclusters shifted toward the original spectrum of the 
colloidal gold nanospheres. The difference between two spectra is due to small number 
(about 7%) of clusters remaining in the dispersion [10]. The result indicates that over time 
the biodegradable nanoclusters degrade to the primary gold nanospheres.   
 
 
Figure 4.3: Block diagram of combined ultrasound and photoacoustic (US/PA) imaging 
system and the gelatin-based tissue mimicking phantom with biodegradable 
nanoclusters inclusion. 
Photoacoustic imaging experiments were performed using tissue mimicking 
phantoms. To simulate the ultrasound and optical scattering properties of tissue, 8% gelatin 
solution with 0.1% (by weight) of 15 µm silica microparticles was poured into a mold. 
Once the gelatin solution was cooled, it formed a base layer of the phantom. To make an 
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inclusion, a single drop of aliquot of the nanocluster suspension at a given concentration 
mixed with gelatin and silica particles was placed at the center of the base layer. The 
inclusion was then cooled and covered with the 8% gelatin solution mixed with 0.1% of 
15 µm silica particles (same as base layer). Four phantoms with inclusions were prepared, 
the concentrations of the nanoclusters in each inclusion were 550, 220, 110 and 55 μg/mL, 
respectively. 
The combined ultrasound and photoacoustic imaging system (Figure 4.3) consisted 
of a pulsed OPO laser system (750 nm wavelength, 7 ns pulse duration, 10 Hz pulse 
repetition frequency), ultrasound transducer (25 MHz center frequency, focal depth = 12.7 
mm, f# = 2), ultrasound pulser/receiver, 3D motion axis, and data acquisition unit. The 
phantoms were irradiated with laser pulses of four different energies: 2, 5, 10.5, and 16.5 
mJ/cm2. The laser light was delivered by optical fiber bundle consisting of 7 fibers of 600 
μm in diameter. During the experiment, the tissue mimicking phantom was placed into a 
water cuvette. The focal point of the ultrasound transducer was positioned at the inclusion’s 
depth and aligned with the laser beam from the optical fiber bundle. A stepper motor 
mechanically scanned the phantom over the imaging region with 50 µm step in lateral 
direction. At each step, the phantom was irradiated by the laser light and the ultrasound 
transducer was used to collect both photoacoustic transients and ultrasound pulse-echo 
signals. The recorded ultrasound and photoacoustic signals were Hilbert transformed, 
bandpass filtered, and spatially interpolated to form spatially co-registered 2-D cross-
sectional ultrasound (US) and photoacoustic (PA) images of the phantoms. 
4.1.2 Results and Discussion 
The US, PA and combined US/PA images of the phantom with inclusion containing 
550 µg/mL concentration of nanoclusters are presented in Figure 4.4a. Each image covers 
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4.7 mm by 4.4 mm field of view. The ultrasound image cannot identify the inclusion within 
the background – this is expected since the nanoclusters do not increase significantly the 
ultrasound backscattering. However, the photoacoustic image clearly differentiates the 
inclusion because the nanoclusters have high optical absorption compared to the 
background. The photoacoustic and ultrasound images can be overlaid to show the position 
of the inclusion within the background.  
The quantitative analysis of the photoacoustic signal amplitude with respect to the 
different laser fluence rate measured from the regions of interest (ROI) containing the 
nanoclusters inclusion is shown in Figure 4.4b. A 2.33 mm × 0.67 mm ROI was selected 
for each photoacoustic image and divided into subareas measuring 0.33 mm × 0.33 mm. 
The mean and the standard deviation of the photoacoustic signal in the subareas were 
plotted as a function of fluence rate of laser. As the laser fluence increases, the amplitude 
of photoacoustic signal from the nanoclusters increases linearly (the R2 value for the linear 
curve fitting is 0.9853). 
The changes in the photoacoustic signal amplitude with concentration of 
nanoclusters are quantified in Figure 4.4c. The solid lines represent the linear fit of the 
photoacoustic signal measured for 5 and 10.5 mJ/cm2 laser fluence rates with R2 equal to 
0.9895 and 0.9901, respectively. As expected, the amplitude of the photoacoustic signal 
from the inclusions increases with the concentration of nanoclusters. These results suggest 
that nanoclusters remain structurally stable under relatively large laser fluences.  
The individual nanospheres have a peak absorbance at around 520 nm wavelength 
and, therefore, isolated spherical nanoparticles cannot be easily detected in photoacoustic 
imaging in vivo because of a spectral overlap with strong absorption of blood and tissue 
scattering. However, aggregation of targeted spherical nanoparticles mediated by 
biological molecules such as growth factor receptors or actin can lead to strong NIR 
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absorption; this approach has been explored for optical [12, 14, 15] and photoacoustic [3-
6] molecular imaging. 
 
 
Figure 4.4: (a) Ultrasound (US), photoacoustic (PA) and combined UA/PA images of 
the phantom with inclusion containing nanoclusters. The concentration of 
the nanoclusters was 550 µg/mL. (b) Photoacoustic signal amplitude with 
respect to fluence rate, and (c) dependence of PA signal on nanocluster 
concentration at 5 and 10.5 mJ/cm2. The solid lines represent the linear 
regression fit of the data. 
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The nanorods are also promising photoacoustic contrast agents due to their high 
absorption cross-section and tunability in the NIR region. However, the nanorods are not 
thermodynamically stable structures and change their shape and, therefore, absorption 
properties, at 8 mJ/cm2 and higher laser fluence [2]. In comparison, the nanoclusters have 
strong NIR absorption and are expected to have reasonable thermodynamic stability thus 
providing an alternative contrast agent for photoacoustic imaging. 
4.2 PHOTO-THERMAL STABILITY OF BIODEGRADABLE NANOCLUSTERS  
During photoacoustic imaging, nanoparticles are exposed to short laser pulses with 
a peak laser power that is extremely high when compared to CW laser irradiation. 
Therefore, the thermal stability of photoacoustic contrast agents is important in producing 
a consistent and reliable photoacoustic signal. Previous studies have shown that gold 
nanorods, which are very promising photoacoustic contrast agents due to their high 
absorption cross-sections in the NIR region, are susceptible to melting and reshaping at the 
laser fluences used in photoacoustic imaging [2, 16-18].  
In this study, the stability of biodegradable nanoclusters of various sizes under 
nanosecond laser pulses was investigated. In addition, the amplitude of the photoacoustic 
signal generated from nanoclusters of different sizes was analyzed and compared with the 
photoacoustic signal produced by the gold nanorods. Based on the thermal stability, optical 
absorption coefficient, and photoacoustic signal strength, the optimal nanocluster size for 
photoacoustic imaging and photothermal therapy is identified. This work was published in 
the journal: S.J. Yoon, A.M. Murthy, K.P. Johnston, K.V. Sokolov, and S.Y. Emelianov, 
“Thermal stability of biodegradable plasmonic nanoclusters in photoacoustic imaging,” 
Optics Express, 20(28):29479-87 (2012). 
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4.2.1 Material and Methods  
Synthesis of Different Sizes of Biodegradable Nanoclusters 
 
 
 
Figure 4.5: (a) Transmission electron microscopy images of 40, 80, 130 nm 
nanoclusters. (b) Size distribution of 40, 80, 130 nm nanoclusters measured 
by DLS. (c) UV-Vis-NIR spectra of 40, 80, and 130 nm nanocluster and 
gold nanorods suspensions at 1.2 mg/mL of gold concentration. 
Biodegradable nanoclusters with controlled sizes from 40 to 130 nm were designed 
and synthesized by varying the ratio of polymer stabilizer to primary gold particles, the 
concentration of gold nanoparticles, and the surface ligands on the primary gold particles. 
Forty nm nanoclusters were formed as described in chapter 4.1.1. The formations of 80 nm 
and 130 nm nanoclusters have been described previously [11]. For 80 nm clusters, 
citrate/lysine capped primary nanoparticles were used with a polymer/Au ratio of 16/1, and 
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for 130 nm clusters, primary nanoparticles were capped by only citrate, and a polymer/Au 
ratio of 16/1 was used. In these cases, a 3 mg/ml Au dispersion was used before 
evaporation. 
The shape and morphology of nanoclusters were observed by transmission electron 
microscopy (TEM) imaging as shown in Figure 4.5(a). The sizes of nanoclusters were 
further characterized by Brookhaven Instruments ZetaPlus dynamic light scattering (DLS) 
apparatus at a scattering angle of 90º and a temperature of 25 ºC in Figure 4.5(b). As shown 
in Figure 4.5(c), the UV-Vis-NIR spectra were collected from different sizes of nanocluster 
suspensions at 1.2 mg/mL of gold concentration in a 96-well microliter plate reader 
(BioTek Synergy HT). The 40 and 80 nm nanoclusters have a broad absorbance while the 
spectrum of 130 nm cluster shows a monotonic decrease in NIR region. In order to compare 
these nanoclusters with other photoacoustic contrast agent, cetyltrimethyl-ammonium 
(CTAB) stabilized gold nanorods were prepared by a seed-mediated growth method [19, 
20]. 
Characterization of the Photothermal Stability of the Biodegradable Nanoclusters 
To test the stability of nanoclusters exposed to a nanosecond pulsed laser 
irradiation, 100 µL nanocluster suspensions of three different sizes (40, 80 and 130 nm) of 
nanoclusters were prepared and placed in a 96-well plate. The concentration of 
nanoparticles in each solution was adjusted by diluting the sample with nanopure water to 
achieve optical density (O.D.) of ~0.6 at 780 nm for each sample. The optical density was 
measured at room temperature using the microplate reader. Each well was then irradiated 
from the top with 300 laser pulses (7 ns pulse duration, 10 Hz repetition rate, 780 nm 
wavelength) generated using a tunable OPO laser system (Vibrant, OPOTEK, Inc.). The 
fluence of the laser beam was varied from 4 to 20 mJ/cm2. Following laser irradiation, the 
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O.D. of each sample was measured again, and the stability of nanoclusters under the 
nanosecond pulsed laser irradiation was assessed by comparison of absorbance spectra 
before and after the laser exposure.   
 
 
Figure 4.6: Block diagram of an experimental setup for photoacoustic signal 
measurement. 
The stability of the photoacoustic signal was explored by measuring the 
photoacoustic signal intensity of 40, 80, 130 nm nanoclusters and nanorods suspensions at 
1.2 mg/mL of gold concentration exposed to 200 pulses with laser fluences ranging from 
4 to 20 mJ/cm2. A custom-built system to measure the photoacoustic signal from a small 
sample of nanoclusters in solution is presented in Figure 4.6. The photoacoustic signals 
from the aqueous nanoparticle solutions were measured as a function of the number of 
pulses. An acrylic PMMA tube with inner diameter of 378 µm and outer diameter of 500 
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µm was positioned in a plastic water cuvette with an optical window for laser irradiation. 
Solutions of nanoclusters of different sizes but with the same overall mass of gold, 
measured by flame atomic absorption spectroscopy (FAAS, GBC Scientific Equipment Pty 
Ltd.), were injected into the tube and were kept stationary during the experiment. A 7.5 
MHz single element ultrasound transducer (focal depth = 50.8 mm, aperture = 12.7 mm) 
was mounted on a one-dimensional translation stage and the focal point of the ultrasound 
transducer was located at the center of the tube containing nanocluster solution. A 
collimated laser beam from nanosecond pulsed laser was incident on the PMMA tube 
through the optical window in the water cuvette. The samples were irradiated with five 
different laser fluences: 4, 8, 12, 16, and 20 mJ/cm2. For each laser pulse, the photoacoustic 
signal was collected by the ultrasound transducer and stored for off-line processing to 
determine the change of photoacoustic signal from each nanocluster solution. At each 
fluence, three independent measurements for each sample were performed. 
Photoacoustic Imaging Setup 
To investigate the importance of the thermal stability of the nanoparticles at high 
laser fluence in photoacoustic imaging, a tissue mimicking phantom was made of 6% 
polyvinyl alcohol (PVA) and 0.2% 15 µm silica by weight was constructed to simulate the 
ultrasound and optical properties of tissue. Four cylindrical compartments of 6 mm in 
diameter were created within the PVA phantom. All compartments were filled with 6 % 
gelatin solution containing the 40, 80, 130 nm nanoclusters and the nanorods. In each 
inclusion, the concentration of nanoclusters and nanorods was standardized to 0.5 mg/mL 
of gold. 
An ultrasound and photoacoustic imaging system (Vevo 2100, Visualsonics, Inc.) 
with an array ultrasound transducer operating at 20 MHz center frequency was used to 
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obtain photoacoustic images of the tissue-mimicking phantom with embedded inclusions. 
At each position, the ultrasound array transducer was placed at the center of the inclusions. 
Nanosecond laser pulses at 780 nm were used to irradiate the samples and 4 photoacoustic 
signals were collected and averaged. The laser fluence was kept at 16 mJ/cm2 which is 
below the safety limit set by American National Standards Institute (ANSI) of 20 mJ/cm2 
in the visible spectral region [21].  
4.2.2 Results and Discussion 
The thermal stabilities of the 40, 80, 130 nm nanoclusters and the nanorods were 
measured using a UV-Vis-NIR spectrophotometer. Figure 4.7 shows the absorbance 
spectra of nanoparticles before and after laser irradiation with 300 pulses at various 
fluencies. Changes in the absorbance spectra indicate that the laser irradiation reaches the 
damage threshold fluence. Laser fluence above 8 mJ/cm2 caused visible spectral changes 
in the 130 nm nanocluster solution. The NIR absorbance of the 130 nm nanoclusters 
dramatically decreased when the fluence was increased to 20 mJ/cm2. Nanoclusters with 
40 and 80 nm sizes showed minimal spectral changes after irradiation with fluences up to 
20 mJ/cm2. Similar to 130 nm nanoclusters, gold nanorods also exhibited reduction in the 
NIR optical absorbance above 8 mJ/cm2 laser fluence. Further increase in the fluence 
induced a strong blue shift of the longitudinal peak of optical absorbance of nanorods in 
the 750-800 nm range. The reduction in the absorbance of the 130 nm nanoclusters is most 
likely associated with degradation of the clusters to their primary particles or the smaller 
clusters because of the corresponding increase in the absorbance at ca. 520 nm; this 
correlation between nanocluster sizes and spectral changes was described previously [11]. 
In the case of nanorods, the changes in the longitudinal plasmon absorption peak between 
760 and 810 nm suggest the reshaping of the nanorods [2, 16, 18]. The results indicate that 
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the 40 and 80 nm nanoclusters have excellent thermal stability under the nanosecond pulsed 
laser as compared to the larger 130 nm nanoclusters as well as gold nanorods. 
 
 
Figure 4.7: UV-Vis-NIR spectra of (a) 40 nm, (b) 80 nm, (c) 130 nm nanoclusters and 
(d) gold nanorods before and after laser irradiation with nanosecond laser 
pulses with various fluences. 
The observed thermal stability of nanoclusters is closely related to their 
composition and binding forces between primary particles forming the clusters. The 40 and 
80 nm clusters were formed using primary Au nanoparticles capped with a combination of 
citrate and lysine ligands and a Z-potential of -30.1 ± 2.4 mV, while the primary 
nanoparticles in 130 nm clusters were capped only with citrate ligand resulting in a Z-
potential of -44.0 ± 4.9 mV. Based on the discernible particles in the periphery of TEM 
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images (see Figure 4.5a), the interparticle distances between the primary gold particles 
within the 40, 80, 130 nm clusters were estimated to be 1.8 ± 0.7, 1.8 ± 0.6, and 2.4 ± 1.4 
nm, respectively. The larger charge repulsion between the citrate capped primary particles 
in 130 nm clusters leads to a more weakly assembled nanocluster and a greater particle-to-
particle spacing in comparison to the 40 and 80 nm clusters. Therefore, the increased 
thermal stability of the 40 and 80 nm clusters can be largely attributed to the relatively 
small interparticle distance incurred by lower electrostatic repulsion, which results in an 
overall more attractive interaction between the primary nanoparticles in the clusters. 
The photoacoustic signal intensity was observed as a function of number of laser 
pulses (Figure 4.8). While the standard deviation was measured in all experiments, for 
visualization purposes the error bars (plus/minus one standard deviation) are only shown 
in Figure 4.8d corresponding to the worst-case condition. A consistent photoacoustic signal 
response from contrast agents in photoacoustic imaging is important because the image 
analysis is based on the assumption that the photoabsorbers remain the same in terms of 
the concentration and absorbance during the imaging. The photoacoustic signal was stable 
for all nanoparticles at 4 mJ/cm2, which is below damage threshold measured by UV-Vis-
NIR spectroscopy (see Figure 4.7). The 40 and 80 nm nanoclusters produced similar 
photoacoustic signals, while the 130 nm nanoclusters only generated a very small 
photoacoustic signal which is just above the background signal measured from the sample 
without nanoparticles. The photoacoustic signals from the 40 and 80 nm nanocluster 
solutions were stable up to 12 mJ/cm2; however, a decay in the signal was observed for 
both nanoclusters exposed to fluences above 12 mJ/cm2. At 20 mJ/cm2, the 40 nm 
nanoclusters produced the highest photoacoustic signal among all the samples, which was 
3.8 times higher than the signal from the nanorod solution. The photoacoustic signal from 
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40 nm nanoclusters increased 4.5 times when the laser fluence was raised from 4 to 20 
mJ/cm2.  
 
 
Figure 4.8: Photoacoustic signal intensity of the 40, 80, 130 nm nanoclusters and the 
nanorods as a function of number of pulses with fluence (a) 4 mJ/cm2, (b) 8 
mJ/cm2, (c) 12 mJ/cm2, and (d) 20 mJ/cm2.  
In general, the photoacoustic signal generated by photoabsorbers is linearly 
increases with the laser fluence. However, the photoacoustic signal from the 40 nm 
nanoclusters only increased 4.5 times while the fluence was increased 5 times. This can be 
attributed to photothermal damage of the nanoclusters which is shown as a small reduction 
in the absorbance at 20 mJ/cm2 (Figure 4.8a). Using the same conditions, the photoacoustic 
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signal increase for the nanorods was only 1.1 times. This can be associated with melting 
and reshaping of the nanorods when exposed to elevated laser fluences. At equivalent gold 
mass concentrations, the measurements indicate that the 40 nm nanoclusters can produce a 
photoacoustic signal that is higher than the nanorods when the fluence is higher than 12 
mJ/cm2 because of their superior photothermal stability and photoacoustic signal 
enhancement due to clustering. 
 
 
Figure 4.8: Photoacoustic images of the phantom with inclusions containing the (a) 40, 
(b) 80, (c) 130 nanoclusters, and (d) nanorods. (e) An ultrasound image of 
the hypoechoic inclusion with hyperechoic background. The photoacoustic 
images were acquired using 16 mJ/cm2 laser fluence. (f) Photoacoustic 
signal intensity of the 40, 80, 130 nm nanoclusters and the nanorods with 
respect to number of pulses at fluence 16 mJ/cm2. 
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Using a tissue-mimicking phantom, the importance of the stability of nanoparticles 
in photoacoustic imaging was demonstrated. The photoacoustic images of the phantom 
with inclusions were obtained at 16 mJ/cm2 laser fluence and 780 nm wavelength 
corresponding to the peak optical absorption wavelength of the nanorods. More than 50 
pulses were used to irradiate each phantom before the photoacoustic images were collected. 
Inclusion with 130 nm nanoclusters produced the weakest photoacoustic signal among the 
samples (Figure 4.9). The photoacoustic signal from 40 nm nanoclusters showed the 
brightest signal at this laser fluence (Figure 4.9a). Interestingly, both the 40 and the 80 nm 
nanoclusters exhibited stronger photoacoustic signal than that of nanorods. These results 
are in good agreement with the results presented in Figure 4.8 where stability of 
nanoparticles was measured at 16 mJ/cm2 laser fluence using the system described in 
Figure 4.6.  
In general, the photoacoustic signal intensity is proportional to the optical 
absorption coefficient of the sample. The absorbance of the 40 nm nanocluster solution 
measured by UV-Vis-NIR spectrometry at 780 nm (λmax of gold nanorods) was only half 
of that of the nanorod solution at the same amount of gold (Figure 4.5c). However, both 
nanoparticles produce similar levels of photoacoustic signal at 4 mJ/cm2, which is below 
the damage threshold for both types of nanoparticles as demonstrated in Figure 4.8a. The 
result clearly indicates that nanoclusters provide an enhanced photoacoustic signal. Several 
mechanisms including optical, thermal [22], and acoustic coupling effects can contribute 
to the enhancement of the photoacoustic signal from closely spaced primary nanoparticles. 
Indeed, a photoacoustic signal enhancement effect and a non-linearity with fluence have 
recently been reported for other forms of clusters [23, 24]. Reasons for this effect could be 
local change in the temperature distribution and thermal conductivity. It has been reported 
that the effective thermal conductivity can be significantly enhanced due to the thermal 
 69 
transport along nanoparticles chains [25]. Others found that the thermal conductivity of 
gold spheres with a polymer shell is higher than predicted, based on the bulk properties 
with the addition of an organic co-solvent to the aqueous medium [26], and it was 
demonstrated that the increased thermal interfacial conductivity enhances the 
photoacoustic signal [17, 27]. Therefore, the enhancement of photoacoustic signal in 
biodegradable plasmonic nanoclusters may be attributed to the laser induced thermal 
coupling, transport effects in clusters, and/or an increased thermal transfer through gold 
interface induced by the clustering and the biodegradable polymer stabilizer. 
4.3 BIODISTRIBUTION STUDY OF BIODEGRADABLE NANOCLUSTERS 
The advance in molecular imaging offers the development of sensitive diagnostics 
and tumor-targeted therapeutics. For many years, there has been tremendous interest in 
developing contrast agents such as gold nanoparticles and nanoparticles can be used for the 
selective delivery of drugs to specific targets [28]. Despite the advance in nanoparticle 
research such as synthesis, characterization, and identification, these advantages can only 
be achieved when in vivo profile of these nanoparticles is fully investigated [29]. Different 
administration routes may cause varying effects on the biodistribution of the nanoparticles. 
In addition, the in vivo biodistribution of the nanoparticles largely depends on their shape, 
size, and chemistry such as surface charge and hydrophobicity [30, 31]. In this section, 
biodegradable nanoclusters are intravenously administrated in mice and the biodistribution 
of the nanoparticles is monitored by photoacoustic imaging.  
4.3.1. Material and Methods 
Animal Preparation 
For ex vivo mouse imaging, 2-4 months old Balb/c female mice were used for this 
clearance study. All animal studies performed for this chapter were approved under 
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Institutional Animal Care and Use Committee (IACUC) protocol AUP-2012-00020. Mice 
were categorized into three groups: solid gold nanosphere-injected, biodegradable 
nanocluster-injected, and PBS-injected mice. Mice were monitored up to 2 months with 
the time points of sacrifice at 1 day, 1 week, 1 month, and 2 months. At each time point, 
photoacoustic imaging was performed after the sacrifice.  
Spectroscopic Photoacoustic Imaging Setup 
VEVO 2100 ultrasound and photoacoustic imaging system (VisualSonics, Inc.) 
was used with a 20 MHz array transducer (VisualSonics, Inc.) as described in chapter 3. 
To differentiate nanoparticles from the background tissue, multi-wavelength photoacoustic 
imaging was performed with fluence of 5-15 mJ/cm2. In this experiment, 9 wavelengths 
from 730 to 890 nm with an increment of 20 nm (i.e., 730, 750, 770, 790, 810, 830, 850, 
870, and 890 nm) were used to obtain photoacoustic images. Spectroscopic photoacoustic 
imaging allows us to differentiate main optical absorbers in tissue, which are oxygenated 
and deoxygenated blood and nanoparticles in this case. At each cross-section, the pulse-to-
pulse laser energy was recorded and compensated for laser energy fluctuation. The 
photoacoustic signals collected from different wavelengths at each cross-section were 
compared to the absorption spectra of oxygenated and deoxygenated hemoglobin and 
nanoparticles. To obtain the correlation coefficients of the absorbers, both linear least 
squares (LLS) and minimum mean square error (MMSE) methods were used [32].  
4.3.2. Results and Discussion 
To monitor the biodistribution of nanoparticles, ex vivo photoacoustic imaging of 
nanoparticle injected mice was performed. Mice were injected via tail vein with 200 μL of 
6 mg/mL of either 40 nm biodegradable nanoclusters or 10 kD PEGylated 40 nm gold 
nanospheres in phenol-free DMEM media. For a control group, PBS was injected into 
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mice. After sacrifice of the mice, the hair was shaved before imaging to remove any 
photoacoustic signal from the hair. Liver and spleen (hypoechoic area in Figure 4.10b-c) 
can be differentiated from other tissue using the anatomical information provided by 
ultrasound images. 
 
Figure 4.10: (a) Photograph of a Balb/c mouse. (b) Ultrasound image of liver and (c) 
spleen. (d) 3D ultrasound image of the mouse. 
Figure 4. 11 shows spectroscopic images of nanoparticles obtained by 
spectroscopic photoacoustic imaging of the mice. For the nanocluster injected mouse at 1 
day, the accumulation of nanoclusters in a liver and a spleen were clearly observed, while 
no nanoparticles were detected in PBS injected mice. The influence on the uptake of 
particles by the mononuclear phagocyte system comprising mainly by the macrophages of 
the liver and spleen after intravenous injection has been discussed in detail elsewhere [33].  
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Figure 4.11: Spectroscopic photoacoustic images of nanoparticle. Nanoparticle maps for 
(a-d) biodegradable nanocluster, (e-h) gold nanospheres, (f-j) PBS injected 
mice at the time points of 1 day, 1 week, 1 month, and 2 months.  
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The photoacoustic signal from nanoclusters dropped at the time point of 1 week 
and kept similar level until the time point of 2 months. There are two possible reasons for 
the signal decrease from the nanoparticles. First, the biodegradable nanoclusters can be 
degraded. However, it does not necessarily mean the clearance of the nanoparticles. Once 
biodegradable nanoclusters degrade, they no longer have broad spectrum in NIR region 
due to the lack of plasmonic coupling between the individual nanoparticles. Similarly, gold 
nanospheres were not detected properly (Figure 4.11e-h) by the current spectroscopic 
photoacoustic imaging setting because gold nanospheres have an absorption peak around 
520 nm but the imaging were performed in the optical window, the wavelength of 730 to 
870 nm. The other possibility of the signal decrease is that only one mouse was imaged at 
the each time point, therefore, the more number of samples are required to conclude the 
reason of dropping the signal. 
4.4 IN VIVO PHOTOACOUSTIC IMAGING OF MICE WITH TUMORS 
Molecular imaging techniques can provide anatomic and functional details of cells 
and tissue which is critical for cancer diagnostics and research. It has a great potential for 
the early stage of tumor detection and effective treatment of diseases. In general, molecular 
imaging relies on external probes that have a high affinity to the specific molecules. There 
has been considerable interest in epidermal growth receptor (EGFR) because of their 
signaling pathway in oncology and maintenance of different types of tumors. One of the 
promising approaches using monoclonal antibodies against EFGR (anti-EGFR) is tested in 
this section [14]. In vitro and in vivo photoacoustic imaging is performed by utilizing anti-
EGFR antibody conjugated biodegradable nanoclusters. 
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4.4.1. Material and Methods 
Tissue Mimicking Phantom Preparation 
Gelatin based tissue-mimicking phantom with cell inclusion were prepared for 
photoacoustic imaging. To mimic tissue properties, 6 % gelatin solution with 0.1 wt% of 
15 μm silica particles was prepared for base and top layers which encapsulated cell 
inclusions. The concentrations of cells are 1 × 106 cells/mL for the all inclusions. Molecular 
specificity of the antibody-conjugated nanoparticles was evaluated in two cell line: EGFR-
positive A431 and EGFR-negative MDA-MB-435 cells. Biodegradable nanoclusters were 
conjugated with anti-EGFR clone 225 antibodies. 5 kD PEGylated biodegradable 
nanoclusters were used as control. Specifically, the inclusions of A431 cells labeled with 
anti-EGFR biodegradable nanoclusters, A431 cells with PEGylated biodegradable 
nanoclusters, MDA-MB-435 cells with anti-EGFR biodegradable nanoclusters and MDA-
MB-435 cells with PEGylated biodegradable nanoclusters were prepared.  
Animal Preparation 
EGFR expressing human A431 cells and EGFR-negative human MDA-MB-435 
cells were incubated in phenol-free DMEM (Invitrogen, 11039) and MEM (Invitrogen, 
41061) culture media, respectively, supplemented with 10% fetal bovine serum (FBS) at 
37˚C in a 5% CO2 environment. Mice were subcutaneously inoculated with both MDA-
MB-435 cells and A431 cells on the same side of the mice and the tumors were allowed to 
grow to about 6 mm in diameter. The mice were then imaged before the injection of either 
anti-EGFR biodegradable nanoclusters or PEGylated biodegradable nanoclusters. 
Photoacoustic imaging was performed at 24 hours post-injection using VEVO LAZR 
system.  
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Ultrasound and Spectroscopic Photoacoustic Imaging Setup 
VEVO LAZR ultrasound and photoacoustic imaging system (VisualSonics, Inc.) 
was used with a 20 MHz array transducer (VisualSonics, Inc.) as described previously. To 
differentiate nanoparticles from the background tissue, spectroscopic photoacoustic 
imaging was perform at 8 different wavelengths (i.e., 740, 750, 760, 800, 840, 880, 920, 
and 960 nm) with fluence of 5-15 mJ/cm2 satisfying an American National Standard 
Institute (ANSI) limit [21]. During the imaging, electrocardiography (ECG) signal was 
monitored and respiration gating was applied to minimize a motion artifact.  
4.4.2. Results and Discussion 
 
Figure 4.12: Photoacoustic images of tissue mimicking phantom. The inclusions include 
A431 cells with PEGylated biodegradable nanocluster, A431 cells with 
nanoclusters conjugated with anti-EGFR clone 225 antibodies, MDA-MB-
435 cells with PEGylated biodegradable nanocluster, and MDA-MB-435 
cells with anti-EGFR clone 225 antibodies, respectively. 
The US, PA and combined US/PA images of the phantom with inclusions, A431 
cells with PEGylated biodegradable nanocluster, A431 cells with nanoclusters conjugated 
with anti-EGFR clone 225 antibodies, MDA-MB-435 cells with PEGylated biodegradable 
nanocluster, and MDA-MB-435 cells with anti-EGFR clone 225 antibodies, respectively, 
are presented in Figure 4.12. Each image covers 20 mm × 10 mm field of view. The laser 
fluence was 13 mJ/cm2 and the images were collected at the wavelength of 700 nm. The 
photoacoustic image of inclusion of A431 cells with anti-EGFR nanoclusters shows strong 
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photoacoustic signal while the rest of the inclusions do not provide any photoacoustic 
signal. The results confirmed that biodegradable nanoclusters were successfully conjugated 
with anti-EGFR clone 225 antibodies.  
Spectroscopic photoacoustic imaging was performed on tumor-bearing mice. Each 
mouse has 2 kinds of the tumor (MDA-MB-435 EGFR(-) and A431 EGFR(+)) on the same 
side of the mouse. Mice were divided into two groups: anti-EGFR biodegradable 
nanoclusters and PEGylated biodegradable nanoclusters injected mice.  
 
 
Figure 4.13: (a) Ultrasound image of MDA-MB-435 and A431 tumor-bearing mouse. (b) 
Spectroscopic photoacoustic image of nanoclusters calculated by 
spectroscopic photoacoustic imaging. (c) Combined US and spectroscopic 
photoacoustic image of nanoclusters.  
Figure 4.13a shows the ultrasound image of the mouse with MDA-MB-435 (left) 
and A431 tumors (right). The spectroscopic images have been spectrally unmixed from a 
set of 8 wavelengths from 740 to 960 nm after the injection of biodegradable nanoclusters 
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conjugated with anti-EGFR clone 225 antibodies. Both linear least squares (LLS) and 
minimum mean square error (MMSE) were used to identify nanoclusters (Figure 4.13b). 
The spectroscopic image shows more accumulation of nanoclusters in the region of the 
A431 tumor compared to that of MDA-MB-435 tumor, indicating that biodegradable 
nanoclusters conjugated with anti-EGFR clone 225 antibodies have higher affinity to the 
A431 tumor. 
 
 
Figure 4.14: (a) A photograph of mouse #1 (b) Spectroscopic photoacoustic image of 
nanoclusters before injection and (c) after injection of anti-EGFR 
biodegradable nanoclusters. (d) A photograph of mouse #2 (e) 
Spectroscopic photoacoustic image of nanoclusters before injection and (f) 
after injection of anti-EGFR biodegradable nanoclusters. 
Figure 4.14 shows the 3D spectroscopic photoacoustic images of biodegradable 
nanoclusters with anti-EGFR 225 antibodies injected mice. Two mice were imaged for the 
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each group. The photographs show the location of two kinds of tumors (Figure 4.14). The 
post-injection spectroscopic photoacoustic image of nanoclusters from mouse #1 shows 
the accumulation of the biodegradable nanoclusters conjugated with anti-EGFR clone 225 
antibodies in A431 tumor. The similar results were obtained from mouse #2. 
Figure 4.15 represents the 3D spectroscopic photoacoustic images of biodegradable 
PEGylated nanoclusters injected mice. Unlike the spectroscopic photoacoustic images 
from the nanoclusters conjugated with anti-EGFR 225 antibodies, the accumulation of the 
biodegradable nanoclusters in a specific tumor was not observed from 2 mice in this group.  
 
 
Figure 4.15: (a) A photograph of mouse #3 (b) Spectroscopic photoacoustic image of 
nanoclusters before injection and (c) after injection of PEGylated 
biodegradable nanoclusters. (d) A photograph of mouse #4 (e) 
Spectroscopic photoacoustic image of nanoclusters before injection and (f) 
after injection of PEGylated biodegradable nanoclusters. 
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4.5 CONCLUSIONS 
In conclusion, the usability of biodegradable nanoclusters (consisting of small 
primary gold nanospheres and a polymeric stabilizer) as a photoacoustic imaging contrast 
agent was explored. It was demonstrated that an inclusion with biodegradable nanoclusters, 
characterized by enhanced absorption within broad NIR spectrum due to plasmon 
resonance coupling between closely spaced primary nanoparticles [10], can be imaged in 
an optically scattering tissue mimicking environment using NIR photoacoustic imaging. It 
is demonstrated that the photoacoustic signal intensity is linearly proportional to the laser 
fluence and concentration of the nanoclusters suggesting their structural and 
thermodynamic stability. The stability of biodegradable plasmonic nanoclusters of three 
different sizes was also investigated in an aqueous solution under nanosecond laser pulses. 
Photoacoustic signals from the nanoparticles at various fluences were also studied and 
compared with that of gold nanorods. The photoacoustic signal amplification from 
clustering of primary gold nanoparticles was observed. The results indicate that 40 nm 
nanoclusters have superior photo-thermal stability for photoacoustic imaging and produce 
stronger photoacoustic signal as compared to nanorods at a given concentration of gold. 
The biodistribution of biodegradable nanoclusters was explored using spectroscopic 
photoacoustic imaging technique. The accumulation of nanoclusters in the liver and spleen 
was observed. Finally, antibody conjugated biodegradable nanoclusters were injected into 
tumor-bearing mice and imaged. The location of antibody conjugated biodegradable 
nanoclusters was presented by the spectroscopic photoacoustic images. In addition, higher 
affinity to the A431 tumor was demonstrated from the biodegradable nanoclusters 
conjugated with anti-EGFR clone 225 antibodies. Overall, the results of the study suggest 
that the biodegradable plasmonic nanoclusters are promising contrast agents for molecular 
photoacoustic imaging and other biomedical applications such as photothermal therapy. 
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Chapter 5: Conclusions and Future Work 
5.1 SUMMARY OF THE RESEARCH 
The objective of this study was to create molecular probes for enhanced 
photoacoustic signal to diagnose the early stage of tumor and improve the therapeutic 
procedure using nanoclusters. In Chapter 2, photothermal stimuli-responsive PNIPAM 
nanoclusters were designed and characterized. PNIPAM-AuNS and PNIPAM-CuS were 
synthesized and photoacoustic signals from these nanoclusters were obtained as a function 
of temperature. By controlling the interparticle distance between primary nanoparticles, 
the photoacoustic signal enhancement from clustering of nanoparticles was demonstrated. 
In Chapter 3, PNIPAM-CuS nanoclusters were used to provide the dynamic contrast in real 
time ex vivo. The stimuli-responsive volumetric changes of the nanoclusters triggered by 
external light source produce an abrupt photoacoustic signal increase which can be 
monitored in real time. Chapter 2 and 3 demonstrated that the nanoclusters can be a 
promising photoacoustic contrast agents. However, using these nanoparticles in vivo may 
cause accumulation of particles and long term toxicity in a body. In Chapter 4, therefore, 
plasmonic biodegradable nanoclusters consisting of sub-5 nm primary gold particles 
stabilized by a weakly adsorbed biodegradable polymer were introduced. The 
photoacoustic signal from biodegradable nanoclusters was quantitatively demonstrated 
using a tissue mimicking phantom. Since photoacoustic contrast agents are exposed to high 
laser fluence, their photothermal stability should be stable. Otherwise, the contrast agents 
do not provide reliable photoacoustic signal. Therefore, the photothermal sensitivity of 
different sizes of nanoclusters was explored to investigate optimal the size of nanoclusters. 
These biodegradable nanoclusters were also utilized to determine biodistribution of 
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nanoparticles. Finally, in vivo photoacoustic imaging was performed on tumor-bearing 
mice using antibody conjugated biodegradable nanoclusters.  
5.2 FUTURE DIRECTIONS 
Although the suggested photothermal stimuli-responsive nanoclusters provide 
excellent dynamic contrast for photoacoustic imaging, there is much room to improve in 
terms of optimizing size of nanocluster and LCST of nanogels. The size of nanocluster 
introduced in this study is 700 nm in diameter when temperature is below the LCST. 
Nanoparticles larger than 200 nm in diameter accumulate in the liver and spleen, where the 
particles are processed by mononuclear phagocyte system (MPS) cells. In addition, larger 
nanoparticles do not extravasate far from blood vessel because they are trapped in 
extracellular matrix between cells. In contrast, nanoparticles smaller than 50 nm penetrate 
deep into tumor tissue [1, 2]. The nanoclusters with 700 nm in diameter still can be used 
for some applications such as lymph node application and drug delivery system, however, 
its applications can be extended further if the size of nanocluster can be reduced. Another 
limitation to the current PNIPAM nanocluster is that LCST temperature is currently 32°C. 
In order to observe dynamic contrast with these nanoclusters in vivo, the LCST have to 
increase to match biological temperature. The studies on reducing nanogel size and 
changing LCST have been discussed by co-polymerizing hydrophilic monomers into the 
polymer matrix [3, 4]. Preliminary results in Figure 5.1 show different sizes of PNIPAM-
AuNS nanoclusters. In addition, PNIPAM nanogels might be toxic when they are 
administered [5] , however, other studies show different results depending on the time scale 
and cell lines [6, 7]. Therefore, a toxicity study of these PNIPAM nanoclusters needs to be 
performed. 
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Figure 5.1: Different sizes of PNIPAM-AuNS nanoclusters. The sizes of nanocluster are 
700, 350, and 150 nm, respectively. 
Spectroscopic photoacoustic imaging is a powerful technique to visualize the 
location of nanoparticles, however, this method takes time to collect images at several 
wavelengths and process the data. The biodegradable nanocluster has broad NIR 
absorbance which is extended to 1064 nm. Therefore, it can be also used for 1064 nm 
contrast agent in photoacoustic imaging. As described previous chapter, there are several 
advantages of using the wavelength of 1064 nm in photoacoustic imaging, if nanoclusters 
can be imaged at 1064 nm. In Figure 5.2b-c, the preliminary results show the combined 
ultrasound/photoacoustic images of 20, 30, and 40 nm nanoclusters injected porcine tissue. 
In Figure 5b, imaged at 700 nm, the location of the injected nanoparticles cannot be 
differentiated from the background noise. In contrast, the presence of nanoparticles is 
clearly visualized in Figure5.2c which is collected at 1064 nm. In addition, the amplitude 
of the photoacoustic signal at 1064 nm will decrease when the nanoclusters are injected 
into a body over time because of the reduction in absorption spectrum of degraded 
nanoclusters. Thus, the degradation stages of the biodegradable nanoclusters can be 
monitored by collecting photoacoustic images at 1064 nm.   
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Figure 5.2: (a) Photograph of the 20, 30, and 40 nm nanoclusters injected porcine tissue 
(b) combined UA/PA images of the porcine tissue with inclusion containing 
20, 30, and 40 nm nanoclusters at 700 nm and (c) 1060 nm 
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